Basics Ikena Oncology, Inc. Common Stock IPO Date: March 22, 2021 Sector: Healthcare Industry: Biotech Market Cap: $56.7M Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 4.18% Avg Daily Range (30 D): $0.03 | 2.36% Avg Daily Range (90 D): $0.03 | 2.37% Institutional Daily Volume Avg Daily Volume: .13M Avg Daily Volume (30 D): .09M Avg Daily Volume (90 D): .08M Trade Size Avg Trade Size (Sh.): 120 Avg Trade Size (Sh.) (30 D): 272 Avg Trade Size (Sh.) (90 D): 237 Institutional Trades Total Inst.Trades: 69 Avg Inst. Trade: $1.97M Avg Inst. Trade (30 D): $1.91M Avg Inst. Trade (90 D): $1.91M Avg Inst. Trade Volume: .35M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.86M Avg Closing Trade (30 D): $4.41M Avg Closing Trade (90 D): $4.41M Avg Closing Volume: 615.09K         News Dec 23, 2024 @ 1:30 PM Ikena Oncology and Inmagene Biopharmaceuticals Ann... Source: Globe Newswire May 29, 2024 @ 7:33 PM Ikena Oncology Discontinues IK-930 Program And Cut... Source: Vandana Singh May 29, 2024 @ 2:17 PM This American Airlines Analyst Is No Longer Bullis... Source: Avi Kapoor May 28, 2024 @ 8:42 PM UPDATE – Ikena Oncology Announces Strategic... Source: Ikena Oncology, Inc. May 28, 2024 @ 8:15 PM Ikena Oncology Announces Strategic Update Source: Ikena Oncology, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.86 $-.18 $-.19 Diluted EPS $-.86 $-.18 $-.19 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -41.71M $ -8.62M $ -9.12M Operating Income / Loss $ -51.54M $ -10.79M $ -12.52M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio